Sandrine Accassat

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial

Marc Righini, J.‐P. Galanaud, H Guenneguez et al. · The Lancet Haematology · 2016 · 174 citations

Medicine, Pharmacotherapy, Clinical Pharmacology +13

Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial

Philippe Robin, Pierre‐Yves Le Roux, Benjamin Planquette et al. · The Lancet Oncology · 2015 · 111 citations

Medicine, Nuclear Medicine, Radiology +16

Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation

Grégoire Le Gal, Michael J. Kovacs, Laurent Bertoletti et al. · Annals of Internal Medicine · 2021 · 76 citations · Full text

Medicine, Hematology, Internal Medicine +16

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17